Mr. Marcello Leone reports

FORTE GROUP ANNOUNCES INITIATIVES TO STRENGTHEN FINANCIAL POSITION

Forte Group Holdings Inc. has arranged a non-brokered private placement financing, consisting of the issuance of an aggregate of three million units of the company at a price of 25 cents per unit for aggregate gross proceeds of up to $750,000, a debt settlement (as defined below), an amendment to a convertible debenture (as defined below), issuance of two convertible loans (as defined below), issuance of amended convertible promissory notes (as defined below) and a potential consolidation (as defined below).

Private placement

Each unit will consist of one common share in the capital of the company and one transferable common share purchase warrant of the company, with each warrant entitling the holder to acquire one additional share at a price of 30 cents per warrant share for a period of two years from the date of closing.

Closing of the private placement is anticipated to occur on or about Sept. 4, 2025, and is subject to certain conditions, including, but not limited to, the receipt of all necessary regulatory approvals, and subject to addressing any comments received from the Canadian Securities Exchange (the CSE) during a five business day period from the date of this news release in accordance with their policies.

The net proceeds of the private placement are intended to be used for general working capital and outstanding payables. The securities issued under the private placement will be subject to a statutory hold period expiring four months and one day from the date of issuance.

Proposed debt settlement

In line with its continued efforts to strengthen its balance sheet, the company intends to settle outstanding debt totalling up to $2.5-million owed to certain creditors of the company in consideration for the issuance of an aggregate 8,771,929 units of the company at a deemed price of 28.5 cents per debt settlement unit.

Each debt settlement unit will consist of one common share in the capital of the company and one transferable common share purchase warrant, with each debt settlement warrant exercisable to purchase one additional common share of the company at an exercise price of 30 cents per debt settlement warrant share for a period of two years from the date of closing of the debt settlement. The securities issued under the debt settlement will be subject to a statutory hold period expiring four months and one day from the date of issuance.

Closing of the debt settlement is anticipated to occur on or about Sept. 4, 2025, and is subject to certain conditions, all necessary regulatory approvals, and subject to addressing any comments received from the CSE during a five-business-day period from the date of this news release in accordance with their policies.

Insiders may participate in the debt settlement, and such participation may constitute a related party transaction under Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions (MI 61-101). The company intends to rely on exemptions from the formal valuation and minority shareholder approval requirements provided under subsections 5.5(a) and 5.7(a) of MI 61-101 on the basis that participation in the debt settlement by insiders will not exceed 25 per cent of the fair market value of the company's market capitalization.

Convertible debenture amendment

The company announces that it intends to amend the terms of a secured convertible debenture dated April 14, 2020, with an arm's-length third party in the principal amount of $500,000 and accrued interest of $94,904.14 for an aggregate of $594,904.14 as at the date hereof. The amended convertible debenture will mature on Dec. 31, 2026, and bear interest at a rate of 8 per cent per annum, calculated daily. Under the original terms of the convertible debenture, it bore interest at a rate of 8 per cent per annum, calculated and payable semi-annually in arrears, was convertible at a price of $150 per common share, and matured on April 14, 2023.

At any time during the term of the amended convertible debenture, the debenture holder may elect to convert the outstanding principal and any accrued and unpaid interest thereon into units of the company at a deemed price of 18.75 cents per convertible debenture unit. Each convertible debenture unit shall consist of one common share of the company and one transferable common share purchase warrant. Each convertible debenture warrant shall entitle the debenture holder to acquire one additional common share of the company at an exercise price of 25 cents per convertible debenture warrant share for a period of three years from the date of issuance.

All securities issued pursuant to the amended convertible debenture will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.

Convertible loan agreements

The company also announces that its wholly owned subsidiary, Naturo Group Enterprises Inc., has entered into two unsecured convertible debenture agreements with two lenders who previously advanced funds to Naturo Group pursuant to purchase order facilitation arrangements. The aggregate principal and lending fees outstanding under the convertible loan agreements is $427,296.99 (U.S.) as at the date hereof. The convertible loans bear interest at a rate of 15 per cent per annum, calculated daily, and mature 24 months from the date of the convertible loan agreements.

At any time during the term of the convertible loans, the lenders may elect to convert the outstanding principal and any accrued and unpaid interest thereon into units of the company at a deemed price of 18.75 cents per convertible loan unit. Each convertible loan unit shall consist of one common share of the company and one transferable common share purchase warrant. Each convertible loan warrant shall entitle the lenders to acquire one additional common share of the company at an exercise price of 25 cents per convertible loan warrant share for a period of three years from the date of issuance.

All securities issued pursuant to the convertible loan agreements will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.

Secured promissory notes amendment

The company also announces that it intends to amend certain secured promissory notes entered into by Naturo Group, with arm's-length third parties in the principal amount of up to $336,000 and accrued interest of $21,254.68, for an aggregate of $357,254.68 as at the date hereof. The amended secured promissory notes will mature on Dec. 31, 2026, and bear interest at a rate of 15 per cent per annum, calculated daily.

At any time during the term of the amended convertible promissory notes, the secured note holders may elect to convert the outstanding principal and any accrued and unpaid interest thereon into units of the company at a deemed price of 18.75 cents per promissory note unit. Each promissory note unit shall consist of one common share of the company and one transferable common share purchase warrant. Each promissory note warrant shall entitle the secured note holders to acquire one additional common share of the company at an exercise price of 25 cents per promissory note warrant share for a period of three years from the date of issuance.

All securities issued pursuant to the amended convertible promissory notes will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities laws.

Potential consolidation

The company also announces that its board of directors has determined that it may be in the best interests of the company to consolidate all of its issued and outstanding common shares. The company intends to seek shareholder approval by written consent from shareholders holding a majority of the number of issued and outstanding common shares approving a consolidation of the outstanding common shares on the basis of up to 25 preconsolidation common shares for one postconsolidation common share, with the actual consolidation ratio to be determined by the board following the receipt of all necessary approvals, including CSE approval, and to occur within one calendar year of the formal approval of the consolidation consent resolution, if at all.

For greater certainty, the consolidation ratio described above represents the maximum consolidation ratio being sought for shareholder approval. Notwithstanding the receipt of such approvals, the board shall have the sole discretion, subject to CSE approval, to determine a lesser consolidation ratio or to determine not to proceed with the consolidation at all. The board's decision in this regard may be made at any time within one calendar year of the formal approval of the consolidation consent resolution, and no assurance can be given that the consolidation will be implemented as described, or at all.

The company intends to seek shareholder approval, by written consent, from shareholders holding a majority of the number of the company's issued and outstanding common shares to approve the consolidation and any other proposed restructuring initiatives set out herein as required by the CSE.

About Forte Group Holdings Inc.

Forte Group Holdings is a next-generation beverage and nutraceutical company focused on longevity and human performance. Through its Trace brand and private-label partnerships, Forte Group develops and manufactures a portfolio of alkaline and mineral-enriched beverages and nutraceutical supplements. Headquartered in British Columbia, Canada, the company owns a pristine natural alkaline spring water aquifer and operates a 40,000-square-foot, Health Canada- and HACCP-certified manufacturing facility near Osoyoos, B.C. Forte Group delivers wellness-driven products through traditional retail and e-commerce channels, providing consumers with innovative solutions to support long-term vitality and well-being.

We seek Safe Harbor.